1. Home
  2. COEP vs HUIZ Comparison

COEP vs HUIZ Comparison

Compare COEP & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • HUIZ
  • Stock Information
  • Founded
  • COEP 2017
  • HUIZ 2006
  • Country
  • COEP United States
  • HUIZ China
  • Employees
  • COEP N/A
  • HUIZ N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • HUIZ Specialty Insurers
  • Sector
  • COEP Health Care
  • HUIZ Finance
  • Exchange
  • COEP Nasdaq
  • HUIZ Nasdaq
  • Market Cap
  • COEP 32.4M
  • HUIZ 29.4M
  • IPO Year
  • COEP N/A
  • HUIZ 2020
  • Fundamental
  • Price
  • COEP $12.45
  • HUIZ $3.08
  • Analyst Decision
  • COEP
  • HUIZ
  • Analyst Count
  • COEP 0
  • HUIZ 0
  • Target Price
  • COEP N/A
  • HUIZ N/A
  • AVG Volume (30 Days)
  • COEP 111.8K
  • HUIZ 12.8K
  • Earning Date
  • COEP 03-25-2025
  • HUIZ 03-19-2025
  • Dividend Yield
  • COEP N/A
  • HUIZ N/A
  • EPS Growth
  • COEP N/A
  • HUIZ N/A
  • EPS
  • COEP N/A
  • HUIZ 0.29
  • Revenue
  • COEP N/A
  • HUIZ $170,927,079.00
  • Revenue This Year
  • COEP N/A
  • HUIZ N/A
  • Revenue Next Year
  • COEP N/A
  • HUIZ $10.46
  • P/E Ratio
  • COEP N/A
  • HUIZ $10.71
  • Revenue Growth
  • COEP N/A
  • HUIZ N/A
  • 52 Week Low
  • COEP $2.31
  • HUIZ $2.15
  • 52 Week High
  • COEP $13.70
  • HUIZ $10.58
  • Technical
  • Relative Strength Index (RSI)
  • COEP 63.21
  • HUIZ 47.29
  • Support Level
  • COEP $8.65
  • HUIZ $2.77
  • Resistance Level
  • COEP $12.95
  • HUIZ $3.23
  • Average True Range (ATR)
  • COEP 1.64
  • HUIZ 0.21
  • MACD
  • COEP -0.16
  • HUIZ -0.01
  • Stochastic Oscillator
  • COEP 75.25
  • HUIZ 42.47

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

Share on Social Networks: